Hirsch David 4
4 · Poseida Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Hirsch David
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+20,000→ 20,000 totalExercise: $8.98Exp: 2031-06-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option will vest and become fully exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the next annual meeting of the stockholders of the Issuer.